Reports for RIZATRIPTAN

Ingredient

RIZATRIPTAN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MAXALT RPD 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-10-16 2019-03-02 64443
MAXALT RPD 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-04-07 2021-08-28 137105
MAXALT RPD 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-09-10 2021-09-30 145497
MAXALT RPD 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-02-23 2023-05-27 185520
MAXALT RPD 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-13 2017-03-16 1344
MAXALT RPD 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-08-23 2023-03-04 167630
MAXALT RPD 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-03-20 2023-04-05 187527
RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-10 2018-02-26 28900
RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-02-15 2019-03-12 75988
RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-04-05 2017-04-12 5659

Showing 1 to 10 of 67

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13544
MINT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13553
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334

Showing 11 to 14 of 14